Shanghai, China - 6 July, 2015 - Shanghai MicroPort Orthopedics Co ("MicroPort® Orthopedics") recently received the registration certificates from China Food and Drug Administration ("CFDA") for its Femoral Head Biolox Delta Ceramic and Rim-Lock Biolox Delta Ceramic Liner. With their market launch, MicroPort® Orthopedics will offer better options to surgeons and patients.

Compared to metal products, the biggest advantages of ceramic products is to reduce wear debris, increase prosthesis survivorship, lower the risks of inflammation and prosthesis dislocation. As the fourth generation of MicroPort® Orthopedics' ceramic products, Femoral Head Biolox Delta Ceramic and Rim-Lock Biolox Delta Ceramic Liner are built on the basis of the third generation Forte Ceramic products with zirconium added to make the material stronger and cracking resistant.

The Biolox ceramic material used in Femoral Head Biolox Delta Ceramic and Rim-Lock Biolox Delta Ceramic Liner has been used to make hip reconstruction products for over 40 years. The material features excellent biocompatibility and scratch resistance to bone cement particles. With its outstanding wettability, it can form effective liquid film lubrication to reduce friction and wear. Up to date, more than 10 million joint prostheses made of Biolox ceramic material have been implanted worldwide.

About MicroPort

MicroPort Scientific Corporation (the "Group") is a leading medical device company with business focusing on innovating, manufacturing, and marketing high-quality and high-end medical devices globally. With a diverse portfolio of products now being used at an average rate of one for every 18 seconds in thousands of major hospitals around the world, the Group maintains world-wide operations in a broad range of business segments including Cardiovascular, Orthopedic, Electrophysiological, Endovascular, Neurovascular, Surgical, Diabetes Care and Endocrinal Management, and others. MicroPort is dedicated to becoming a patient oriented global enterprise improve and reshape patient lives through application of innovative science and technology.

For more information, please refer to: www.microport.com

Forward-Looking Statements

Some information contained on this website contains forward-looking statements. These forward-looking statements include, without limitation, those regarding our future financial position, our strategy, plans, objectives, goals and targets, future developments in the markets where we participate or are seeking to participate, and any statements preceded by, followed by or that include the words "believe", "intend", "expect", anticipate", "project", "estimate", "predict", "is confident", "has confidence" and similar expressions are also intended to identify forward-looking statements. Such statements are based upon the current beliefs and expectations of MicroPort's management and are subject to significant risks and uncertainties. MicroPort Scientific Corporation undertakes no obligation to update any of the statements. These forward-looking statements are not guarantees of future performance and are subject to risks, uncertainties and other factors that could cause actual future results to differ materially from current expectations include, but are not limited to, general industry and economic conditions, PRC governmental policies and regulations relating to the medical device manufacturing industry, competition in the medical device manufacturing industry, our ability to develop new products and stay abreast of market trends and technological advances, our goals and strategies, our ability to execute strategic acquisitions of, investments in or alliances with other companies and businesses, fluctuations in general economic and business conditions in China.

This document is for information purposes only and does not constitute or form part of any offer or invitation to sell or the solicitation of an offer or invitation to purchase or subscribe for any securities of MicroPort Scientific Corporation, and no part of it shall form the basis of, or be relied upon in connection with, any agreement, arrangement, contract, commitment or investment decision in relation thereto whatsoever.

All rights reserved.
Copyright © 2015 MicroPort Scientific Corporation

CONTACT:
Jonathan Chen
Senior Vice President, International Operations and Investor Relations
MicroPort Scientific Corporation
Tel: (86)(21) 38954600
Email: jonathanchen@microport.com
Xun You
Board Secretary
Shanghai MicroPort Medical (Group) Co., Ltd. (HQ)
Tel: (86)(21) 38954600-6959
Email: ir@microport.com
distributed by